ASCC2 Inhibitors

ASCC2 inhibitors as a chemical class would encompass a diverse set of compounds that can indirectly affect the function of ASCC2 by targeting the pathways and processes in which it is involved. Since ASCC2 is part of the ASCC complex that has roles in transcriptional regulation and the alkylation damage response, inhibitors in this class can influence the protein's activity by altering chromatin dynamics or interfering with the cellular response to DNA damage.

Histone deacetylase inhibitors like Trichostatin A and Vorinostat can modify the chromatin state, impacting the transcriptional control exerted by the ASCC complex. Similarly, DNA methyltransferase inhibitors such as 5-Azacytidine can change gene expression profiles, potentially affecting the transcriptional regulatory functions in which ASCC2 is implicated. Alkylating agents like Methyl methanesulfonate and DNA crosslinking agents such as Cisplatin induce DNA lesions that invoke the DNA repair machinery, where ASCC2 might have a role. PARP inhibitors, including Olaparib and Veliparib, can disrupt the DNA damage response, which could influence ASCC2's activity in alkylation damage repair. Other compounds such as ATM kinase inhibitors (e.g., Ku-55933), tyrosine kinase inhibitors (e.g., Nilotinib), topoisomerase inhibitors (e.g., Etoposide), MRE11 inhibitors (e.g., Mirin), and DNA-PKcs inhibitors (e.g., NU7441) can affect various aspects of DNA damage response and repair. By inhibiting these key components and pathways, these compounds can indirectly modulate the function of ASCC2 within the ASCC complex